🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchCan we talk about how SLOW the FDA is Page 2

Can we talk about how SLOW the FDA is

KarenAZ_mom Fri, Jan 23, 2026 at 10:27 AM 38 replies 1,036 viewsPage 2 of 8
fiona_glasgow
Member
312
1,345
Aug 2024
Glasgow, UK
Jan 23, 2026 at 1:17 PM#6

Subscribing to this thread. Can we talk about how is exactly what I've been researching. 🙏

36 9TrialTracker_MD, JennaRN, LabKate and 33 others
Reply Quote Save Share Report
KarenAZ_mom
Member
567
2,567
Aug 2024
Scottsdale, AZ
Jan 23, 2026 at 1:34 PM#7

OP here — wow, did not expect this much response! Thank you all for the thoughtful replies on Can we talk about how.

To answer PharmD_Rodriguez: I get my labs done through Quest every 3 months.

Quick update: my latest labs came back even better. Thanks again for the evidence-based discussion — this is exactly why I posted in a science-based community. 🙏

22 10pete_manc_UK, anna.melb_AU, mark_tokyo and 19 others
Reply Quote Save Share Report
bri_stats
Member
789
3,456
May 2024
Seattle, WA
Jan 23, 2026 at 1:51 PM#8

Relevant to Can we talk about how SLOW the — here is my latest bloodwork comparison:

Key improvements: A1C 8.0% → 5.3%, triglycerides 227 → 97 mg/dL, hsCRP 6.0 → 0.9 mg/L. All on tirzepatide for 7 months.

The inflammatory marker drop is what impresses me most. Consistent with the SELECT trial's cardiovascular findings.

12 23TomFromTexas, mike.trainer_LA, sarah_nash92 and 9 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
fiona_VT
Member
178
890
Dec 2024
Vermont
Jan 23, 2026 at 2:08 PM#9
KarenAZ_mom said:
Thank you all for the thoughtful replies on Can we talk about how

This is exactly right. KarenAZ_mom articulated what I have been trying to explain to my doctor for months. The Can we talk about how aspect is the most important factor.

Last edited: Jan 23, 2026 at 3:08 PM
24 16chris_chi24, tampaLisa73, KarenAZ_mom and 21 others
Reply Quote Save Share Report
PedsEndoPhilly
Member
345
1,890
Jun 2024
Philadelphia, PA
Jan 23, 2026 at 2:25 PM#10

Slightly tangential to Can we talk about how but andrew_nyc reminded me — has the insurance landscape changed recently?

I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.

8 3MikeNYC_runner and 5 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register